Search
Now showing items 1-10 of 16
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19
| Date Issued:
2022 | Copyright:
open access
Article
Increased platelet activation and platelet-inflammasome engagement during chikungunya infection
| Date Issued:
2022 | Copyright:
open access
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access
Article
Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil
| Date Issued:
2019 | Copyright:
open access
Article
Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil
| Date Issued:
2021 | Copyright:
open access
Article
Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection
| Date Issued:
2019 | Copyright:
open access
Article
An observational clinical case of Zika virus-associated neurological disease is associated with primary IgG response and enhanced TNF levels
| Date Issued:
2018 | Copyright:
restricted access
Article
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access
Article
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
| Date Issued:
2017 | Copyright:
open access